Stock 2160 MICROPORT CARDIOFLOW MEDTECH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Ratings MicroPort CardioFlow Medtech Corporation

Equities

2160

KYG6082P1054

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 am EDT 		5-day change 1st Jan Change
1.01 HKD -.--% Intraday chart for MicroPort CardioFlow Medtech Corporation -2.88% -37.65%
May. 10 MicroPort CardioFlow Medtech's Medical Device Secures Breakthrough Designation from FDA MT
Apr. 16 Microport Cardioflow Inks Services Deal with Subsidiary MT

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
MICROPORT CARDIOFLOW MEDTECH CORPORATION Stock MicroPort CardioFlow Medtech Corporation
-37.65% 312M -
STRYKER CORPORATION Stock Stryker Corporation
+13.73% 130B
A-
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.17% 10.99B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-4.33% 8.35B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+41.80% 5.67B
B+
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.94% 4.72B
C
AXONICS, INC. Stock Axonics, Inc.
+7.81% 3.42B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-10.26% 2.76B
B-
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-10.29% 2.11B - -
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.58% 1.92B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2160 Stock
  4. Ratings MicroPort CardioFlow Medtech Corporation